↓ Skip to main content

Dove Medical Press

Article Metrics

microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction]

Overview of attention for article published in OncoTargets and therapy, September 2021
Altmetric Badge

Mentioned by

twitter
1 tweeter
Title
microRNA-628 Inhibits the Proliferation of Acute Myeloid Leukemia Cells by Directly Targeting IGF-1R [Retraction]
Published in
OncoTargets and therapy, September 2021
DOI 10.2147/ott.s339844
Pubmed ID
Authors

Lu Chen, Xin Jiang, Haoyue Chen, Qiaoyan Han, Chunhua Liu, Miao Sun

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 September 2021.
All research outputs
#18,271,715
of 20,593,249 outputs
Outputs from OncoTargets and therapy
#1,805
of 2,796 outputs
Outputs of similar age
#280,226
of 346,733 outputs
Outputs of similar age from OncoTargets and therapy
#3
of 3 outputs
Altmetric has tracked 20,593,249 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,796 research outputs from this source. They receive a mean Attention Score of 2.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 346,733 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one.